| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33669f0c97c828afff6bfec95496769a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
2001-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_806423b03f5a34ae022d4ffea650b64b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4aab3de138c5296ee28a60070f40c56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f6c23edd56046ac3c35e8e3aff813cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27573d2e2a28404cee460ba8895f1ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61bcc0d9fb1de0fca155bcfbef81cad2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8ddc4e98f9a330eea19a93087ab9123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5864efe3c434ddc2277b17ea921e4c76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eaf62fe0ebb6a423f58da821c4e1b84 |
| publicationDate |
2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7662552-B2 |
| titleOfInvention |
Method of diagnosing and treating lesion of crystalline lens using human CRYGS gene and coding product thereof |
| abstract |
The method of diagnosing lesions of crystalline lens such as cataract is disclosed. It comprises detecting variation of crygs gene, transcript and/or protein of individuals compared with normalty. The individual suffers from cataract more possible than normalty when occurring the variation. The present invention also discloses the method and pharmaceutical composition of treating lesions of crystalline lens such as cataract. |
| priorityDate |
2000-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |